This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells
British Journal of Cancer Open Access 16 December 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mistry AR, Pedersen EW, Solomon E, Grimwade D . The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease. Blood Rev 2003; 17: 71–97.
He L-Z, Tolentino T, Grayson P, Zhong S, Warrell Jr RP, Rifkind RA et al. Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. J Clin Invest 2001; 108: 1321–1330.
Kitamura K, Hoshi S, Koike M, Kiyoi H, Naoe T . Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid. Br J Haematol 2000; 108: 696–702.
Warrell Jr RP, He L-Z, Richon V, Calleja E, Pandolfi PP . Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor histone deacetylase. J Natl Cancer Inst 1998; 90: 1621–1625.
Göttlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001; 20: 6969–6978.
Insinga A, Monestiroli S, Ronzoni S, Gelmetti V, Marchesi F, Viale A et al. Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway. Nat Med 2005; 11: 71–76.
Zhou D-C, Kim SH, Ding W, Schultz C, Warrell Jr RP, Gallagher RE . Frequent mutations in the ligand-binding domain of PML-RARα after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo. Blood 2002; 99: 1356–1363.
Diverio D, Rossi V, Avvisati G, De Santis S, Pustilli A, Pane F et al. Early detection of relapse by prospective reverse transcriptive-polymerase chain reaction analysis of the PML/RARα fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter ‘AIDA’ trial. Blood 1998; 92: 784–789.
Acknowledgements
We are grateful to Fabien Guidez for critical reading of the manuscript and to the Special Trustees of Guy's Hospital for assistance in purchase of ABI7700. EN and molecular studies were supported by Leukaemia Research Fund of Great Britain (0153). We thank Michaela Ward for her assistance with this report and Professor Charles Craddock for interesting discussions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McMullin, M., Nugent, E., Thompson, A. et al. Prolonged molecular remission in PML-RARα-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate. Leukemia 19, 1676–1677 (2005). https://doi.org/10.1038/sj.leu.2403883
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403883
This article is cited by
-
Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells
British Journal of Cancer (2015)